Keli Walbert - Director at Apellis Pharmaceuticals, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Director
Stock Symbol
APLS on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Keli Walbert since 4/22/2024

Holdings reported by Keli Walbert for Apellis Pharmaceuticals, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Stock Option (Right to Buy) 15.4K $508K $33.00 Jan 8, 2025 Direct Common Stock
Common Stock 9.09K $307K $33.81 Jan 8, 2025 Direct

Transactions reported by Keli Walbert for Apellis Pharmaceuticals, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.